242 related articles for article (PubMed ID: 32517647)
1. Tolfenamic acid inhibits GSK-3β and PP2A mediated tau hyperphosphorylation in Alzheimer's disease models.
Zhang H; Wang X; Xu P; Ji X; Chi T; Liu P; Zou L
J Physiol Sci; 2020 Jun; 70(1):29. PubMed ID: 32517647
[TBL] [Abstract][Full Text] [Related]
2. PP2A regulates tau phosphorylation directly and also indirectly via activating GSK-3beta.
Qian W; Shi J; Yin X; Iqbal K; Grundke-Iqbal I; Gong CX; Liu F
J Alzheimers Dis; 2010; 19(4):1221-9. PubMed ID: 20308788
[TBL] [Abstract][Full Text] [Related]
3. Cornel Iridoid Glycoside Inhibits Tau Hyperphosphorylation via Regulating Cross-Talk Between GSK-3β and PP2A Signaling.
Yang C; Li X; Gao W; Wang Q; Zhang L; Li Y; Li L; Zhang L
Front Pharmacol; 2018; 9():682. PubMed ID: 29997510
[TBL] [Abstract][Full Text] [Related]
4. Glycogen synthase kinase-3β regulates Tyr307 phosphorylation of protein phosphatase-2A via protein tyrosine phosphatase 1B but not Src.
Yao XQ; Zhang XX; Yin YY; Liu B; Luo DJ; Liu D; Chen NN; Ni ZF; Wang X; Wang Q; Wang JZ; Liu GP
Biochem J; 2011 Jul; 437(2):335-44. PubMed ID: 21554241
[TBL] [Abstract][Full Text] [Related]
5. Cross talk between PI3K-AKT-GSK-3β and PP2A pathways determines tau hyperphosphorylation.
Wang Y; Yang R; Gu J; Yin X; Jin N; Xie S; Wang Y; Chang H; Qian W; Shi J; Iqbal K; Gong CX; Cheng C; Liu F
Neurobiol Aging; 2015 Jan; 36(1):188-200. PubMed ID: 25219467
[TBL] [Abstract][Full Text] [Related]
6. Microcystin-Leucine-Arginine Induces Tau Pathology Through Bα Degradation via Protein Phosphatase 2A Demethylation and Associated Glycogen Synthase Kinase-3β Phosphorylation.
Zhang Y; Zhang J; Wang E; Qian W; Fan Y; Feng Y; Yin H; Li Y; Wang Y; Yuan T
Toxicol Sci; 2018 Apr; 162(2):475-487. PubMed ID: 29228318
[TBL] [Abstract][Full Text] [Related]
7. Tolfenamic acid reduces tau and CDK5 levels: implications for dementia and tauopathies.
Adwan L; Subaiea GM; Basha R; Zawia NH
J Neurochem; 2015 Apr; 133(2):266-72. PubMed ID: 25279694
[TBL] [Abstract][Full Text] [Related]
8. 17beta-estradiol attenuates glycogen synthase kinase-3beta activation and tau hyperphosphorylation in Akt-independent manner.
Shi HR; Zhu LQ; Wang SH; Liu XA; Tian Q; Zhang Q; Wang Q; Wang JZ
J Neural Transm (Vienna); 2008 Jun; 115(6):879-88. PubMed ID: 18217188
[TBL] [Abstract][Full Text] [Related]
9. Role of microtubule-associated protein tau phosphorylation in Alzheimer's disease.
Ma RH; Zhang Y; Hong XY; Zhang JF; Wang JZ; Liu GP
J Huazhong Univ Sci Technolog Med Sci; 2017 Jun; 37(3):307-312. PubMed ID: 28585125
[TBL] [Abstract][Full Text] [Related]
10. Ginsenoside Rd attenuates beta-amyloid-induced tau phosphorylation by altering the functional balance of glycogen synthase kinase 3beta and protein phosphatase 2A.
Li L; Liu Z; Liu J; Tai X; Hu X; Liu X; Wu Z; Zhang G; Shi M; Zhao G
Neurobiol Dis; 2013 Jun; 54():320-8. PubMed ID: 23321003
[TBL] [Abstract][Full Text] [Related]
11. Cytoplasmic retention of protein phosphatase 2A inhibitor 2 (I2PP2A) induces Alzheimer-like abnormal hyperphosphorylation of Tau.
Arif M; Wei J; Zhang Q; Liu F; Basurto-Islas G; Grundke-Iqbal I; Iqbal K
J Biol Chem; 2014 Oct; 289(40):27677-91. PubMed ID: 25128526
[TBL] [Abstract][Full Text] [Related]
12. Morroniside-Induced PP2A Activation Antagonizes Tau Hyperphosphorylation in a Cellular Model of Neurodegeneration.
Yang CC; Kuai XX; Gao WB; Yu JC; Wang Q; Li L; Zhang L
J Alzheimers Dis; 2016; 51(1):33-44. PubMed ID: 26836014
[TBL] [Abstract][Full Text] [Related]
13. SLM, a novel carbazole-based fluorophore attenuates okadaic acid-induced tau hyperphosphorylation via down-regulating GSK-3β activity in SH-SY5Y cells.
Wu X; Kosaraju J; Tam KY
Eur J Pharm Sci; 2017 Dec; 110():101-108. PubMed ID: 28359686
[TBL] [Abstract][Full Text] [Related]
14. Effects of Single-Dose and Long-Term Ketamine Administration on Tau Phosphorylation-Related Enzymes GSK-3β, CDK5, PP2A, and PP2B in the Mouse Hippocampus.
Li Y; Wen G; Ding R; Ren X; Jing C; Liu L; Yao J; Zhang G; Lu Y; Li B; Wu X
J Mol Neurosci; 2020 Dec; 70(12):2068-2076. PubMed ID: 32705526
[TBL] [Abstract][Full Text] [Related]
15. GSK-3β is Dephosphorylated by PP2A in a Leu309 Methylation-Independent Manner.
Chu D; Tan J; Xie S; Jin N; Yin X; Gong CX; Iqbal K; Liu F
J Alzheimers Dis; 2016; 49(2):365-75. PubMed ID: 26484916
[TBL] [Abstract][Full Text] [Related]
16. [Effects of
Zhang X; Wei YT; Wang JY; Liu HX; Zhu TT; Yan XK
Zhongguo Zhen Jiu; 2023 Jul; 43(7):793-9. PubMed ID: 37429659
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of NLRP1-Dependent Pyroptosis Prevents Glycogen Synthase Kinase-3β Overactivation-Induced Hyperphosphorylated Tau in Rats.
Liu X; Song W; Yu Y; Su J; Shi X; Yang X; Wang H; Liu P; Zou L
Neurotox Res; 2022 Oct; 40(5):1163-1173. PubMed ID: 35951283
[TBL] [Abstract][Full Text] [Related]
18. C-terminal truncation of GSK-3β enhances its dephosphorylation by PP2A.
Jin N; Wu Y; Xu W; Gong CX; Iqbal K; Liu F
FEBS Lett; 2017 Apr; 591(7):1053-1063. PubMed ID: 28267204
[TBL] [Abstract][Full Text] [Related]
19. Dendrobium nobile Lindl. alkaloid decreases Tau hyperphosphorylation via regulating PI3K/Akt/GSK-3β pathway in vitro and in vivo.
Huang J; Huang N; Qiu Y; Shi J
J Ethnopharmacol; 2024 Mar; 322():117592. PubMed ID: 38097026
[TBL] [Abstract][Full Text] [Related]
20. Perinatal exposure to lead (Pb) promotes Tau phosphorylation in the rat brain in a GSK-3β and CDK5 dependent manner: Relevance to neurological disorders.
Gąssowska M; Baranowska-Bosiacka I; Moczydłowska J; Tarnowski M; Pilutin A; Gutowska I; Strużyńska L; Chlubek D; Adamczyk A
Toxicology; 2016 Mar; 347-349():17-28. PubMed ID: 27012722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]